US Broker Ratings

Chemed Corp (CHE) Stock Analysis: Navigating Growth in Healthcare with a Strong ROE of 25.6%

Chemed Corp (NYSE: CHE) stands as a formidable player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $6.15..

BridgeBio Pharma, Inc. (BBIO): Investor Outlook Highlights 45.61% Potential Upside Amid Robust Pipeline

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing the attention of investors with its compelling growth potential in the biotechnology sector. As a key player in healthcare,..

ResMed Inc. (RMD) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is catching the eye of investors with its robust market capitalization of $29.05 billion and..

Bruker Corporation (BRKR) Stock Analysis: Navigating Challenges with Strategic Innovations

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, has been at the forefront of technological advancements in..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 47% Upside Potential in Biotech Innovation

BeOne Medicines Ltd. (ONC), a burgeoning name in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of oncology treatments and a..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 31.66% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands out in the biotechnology sector with its potent mix of innovation and financial resilience. As a leader in the healthcare..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 19.79% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in the development and commercialization of bioprocessing technologies and systems. With a market capitalization..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 47.76% Potential Upside in Diagnostic Imaging

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with a compelling potential upside of..

Royalty Pharma (RPRX) Stock Analysis: Evaluating Its 5.37% Potential Upside and Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player in the biotechnology sector, operating primarily as a buyer of biopharmaceutical royalties while funding innovation in..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating Its $9.77B Market Cap with Promising Cancer Therapies

Nuvalent, Inc. (NUVL), a clinical-stage biopharmaceutical company, has been making waves in the healthcare sector with its innovative approach to developing therapies for cancer patients. With..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 101% Upside Potential with Strong Buy Ratings

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology industry, is capturing investor attention with its impressive potential upside of 101.14%. Operating within the..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Tightrope with Potential and Caution

Bio-Techne Corp (NASDAQ: TECH) is a significant player in the biotechnology sector, operating at the crossroads of healthcare and technology. With a market capitalization of $11.06..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring Growth Potential Amidst Notable Revenue Surge

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has been capturing investor interest with its impressive market performance and innovative therapeutic solutions...

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth with a $10.39 Billion Market Cap

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector specializing in diagnostics and research, is drawing attention with its impressive market..

Alkermes plc (ALKS) Stock Analysis: Navigating Growth Amidst a Potential -12.63% Downside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, has been attracting significant attention from investors with its robust lineup of pharmaceutical products targeting..

Natera, Inc. (NTRA) Stock Analysis: A Leading Diagnostic Innovator with Robust Revenue Growth and Strong Buy Ratings

Investors with a keen eye on the healthcare sector may find Natera, Inc. (NASDAQ: NTRA) an intriguing opportunity. As a prominent player in the diagnostics and..

Zoetis Inc. (ZTS) Stock Analysis: Is a 62.96% Upside Worth the Investment?

For investors eyeing the healthcare sector, Zoetis Inc. (ZTS) presents a compelling opportunity with a significant potential upside of 62.96%, according to analyst ratings. With a..

West Pharmaceutical Services (WST) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings Offer Promising Prospects

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector with a focus on medical instruments and supplies, has been capturing investor attention..

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Sector with a -5.93% Potential Downside

Centene Corporation (NYSE: CNC), a significant player in the healthcare plans industry, presents an intriguing case for investors navigating the dynamic healthcare sector. With a market..

Guardant Health, Inc. (GH) Stock Analysis: Navigating High Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its cutting-edge diagnostic technologies. Headquartered in Palo Alto,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds